{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:28:23Z","timestamp":1786490903052,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2024J011336"],"award-info":[{"award-number":["2024J011336"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jcyt.2026.102123","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:13:42Z","timestamp":1771892022000},"page":"102123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-tumor effects of CD133-targeted CAR-NK92MI cells in colorectal cancer"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5665-0611","authenticated-orcid":false,"given":"Yuyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailing","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongquan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcyt.2026.102123_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"10449","key":"10.1016\/j.jcyt.2026.102123_bib0002","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(24)00360-X","article-title":"Colorectal cancer","volume":"404","author":"Eng","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jcyt.2026.102123_bib0003","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1307","article-title":"Comparison of the short- and long-term prognosis of early-onset colorectal cancer compared with later-onset colorectal cancer: A systematic review and meta-analysis","volume":"6","author":"Jin","year":"2023","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.jcyt.2026.102123_bib0004","first-page":"4","article-title":"The oretical basis and operative difficulties of whole-course membrane anatomy in laparoscopic low rectal cancer surgery","volume":"30","author":"Yunjie Shi","year":"2024","journal-title":"J Colorectal Anal Surg"},{"key":"10.1016\/j.jcyt.2026.102123_bib0005","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12943-022-01663-0","article-title":"The journey of CAR-T therapy in hematological malignancies","volume":"21","author":"Lu","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jcyt.2026.102123_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2021.100826","article-title":"CAR T-cell therapy for B-cell lymphoma","volume":"46","author":"Denlinger","year":"2022","journal-title":"Curr Probl Cancer"},{"issue":"26","key":"10.1016\/j.jcyt.2026.102123_bib0007","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-Cell therapy in refractory large B-Cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"issue":"10254","key":"10.1016\/j.jcyt.2026.102123_bib0008","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(20)31366-0","article-title":"Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study","volume":"396","author":"Abramson","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jcyt.2026.102123_bib0009","first-page":"1744","article-title":"Fever characteristics and biomarker changes of CRS in patients with relapsed\/refractory multiple myeloma after CAR-T Cell therapy","volume":"32","author":"Hua","year":"2024","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"10.1016\/j.jcyt.2026.102123_bib0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/jnci\/djz017","article-title":"CAR T-cell associated neurotoxicity: mechanisms, clinicopathologic correlates, and future directions","volume":"111","author":"Hunter","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.jcyt.2026.102123_bib0011","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","article-title":"CAR-T therapy in solid tumors","volume":"43","author":"Du","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcyt.2026.102123_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13435","article-title":"Recognition of self and viral ligands by NK cell receptors","volume":"329","author":"Mariuzza","year":"2025","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.jcyt.2026.102123_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009126","article-title":"Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer","volume":"12","author":"Wessel","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jcyt.2026.102123_bib0014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/imr.13316","article-title":"Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment","volume":"323","author":"Moinuddin","year":"2024","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jcyt.2026.102123_bib0015","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41423-024-01207-0","article-title":"CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors","volume":"21","author":"Peng","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jcyt.2026.102123_bib0016","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","article-title":"Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19(+) B cell tumors: a phase 1\/2 trial","volume":"30","author":"Marin","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2026.102123_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1383136","article-title":"CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma","volume":"15","author":"Moles","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102123_bib0018","first-page":"228","article-title":"Target selection of CAR T cell therapy in accordance with the TME for solid tumors","volume":"9","author":"Liu","year":"2019","journal-title":"Am J Cancer Res"},{"issue":"6","key":"10.1016\/j.jcyt.2026.102123_bib0019","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/toxins8060165","article-title":"CD133, Selectively Targeting the Root of Cancer","volume":"8","author":"Schmohl","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jcyt.2026.102123_bib0020","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3748\/wjg.v17.i7.932","article-title":"Upregulated CD133 expression in tumorigenesis of colon cancer cells","volume":"17","author":"Yang","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcyt.2026.102123_bib0021","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1158\/0008-5472.CAN-08-2023","article-title":"Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition","volume":"69","author":"Dallas","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcyt.2026.102123_bib0022","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1245\/s10434-016-5099-1","article-title":"CD133 expression at the metastatic site predicts patients\u2019 outcome in colorectal cancer with synchronous liver metastasis","volume":"23","author":"Kishikawa","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jcyt.2026.102123_bib0023","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/sj.bjc.6604437","article-title":"CD133\/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers","volume":"99","author":"Smith","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcyt.2026.102123_bib0024","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12015-023-10647-6","article-title":"Functional roles of CD133: more than stemness associated factor regulated by the microenvironment","volume":"20","author":"Moreno-Londo\u00f1o","year":"2024","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.jcyt.2026.102123_bib0025","first-page":"7211","article-title":"CD133 mediates the TGF-\u03b21-induced activation of the PI3K\/ERK\/P70S6K signaling pathway in gastric cancer cells","volume":"14","author":"Zhu","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jcyt.2026.102123_bib0026","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1089\/hum.2017.168","article-title":"Improved killing of ovarian cancer stem cells by combining a novel chimeric antigen receptor-based immunotherapy and chemotherapy","volume":"28","author":"Klapdor","year":"2017","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jcyt.2026.102123_bib0027","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1158\/1078-0432.CCR-08-2810","article-title":"2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells","volume":"15","author":"Altvater","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcyt.2026.102123_bib0028","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jtct.2022.06.025","article-title":"The next generation of cellular immunotherapy: chimeric antigen receptor-natural killer cells","volume":"28","author":"Moscarelli","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2026.102123_bib0029","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccell.2020.01.006","article-title":"Unraveling the signaling balance of activation and exhaustion of CAR T cells","volume":"37","author":"Scarf\u00f2","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcyt.2026.102123_bib0030","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1038\/s41467-020-18444-2","article-title":"Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma","volume":"11","author":"Tseng","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcyt.2026.102123_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101065","article-title":"Construction of self-driving anti-\u03b1FR CAR-engineered NK cells based on IFN-\u03b3 and TNF-\u03b1 synergistically induced high expression of CXCL10","volume":"58","author":"He","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.jcyt.2026.102123_bib0032","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/icb.2009.35","article-title":"Human NK cell lines migrate differentially in vitro related to matrix interaction and MMP expression","volume":"87","author":"Edsparr","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jcyt.2026.102123_bib0033","doi-asserted-by":"crossref","unstructured":"Justus CR, Leffler N, Ruiz-Echevarria M, Yang LV. In vitro cell migration and invasion assays. J Vis Exp. 2014;88:51046. https:\/\/doi.org\/10.3791\/51046.","DOI":"10.3791\/51046"},{"key":"10.1016\/j.jcyt.2026.102123_bib0034","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2026.102123_bib0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.omtm.2022.10.010","article-title":"Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-\u03b2","volume":"27","author":"Chaudhry","year":"2022","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532492600085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532492600085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:38:58Z","timestamp":1786487938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146532492600085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S146532492600085X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102123","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-tumor effects of CD133-targeted CAR-NK92MI cells in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of International Society for Cell and Gene Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102123"}}